# Consensus and original-source cross-check: Telomere Shortening Theory of Aging

Literature cutoff: 9 October 2026. Reconciliation completed 11 October 2026. Consensus Pro browser output is a discovery/synthesis aid; original source sections determine attribution. Provider meters are not evidence probabilities or examined-primary counts.

## Telomerase restoration can reverse degeneration.
Original body restricts this rescue to late-generation telomerase-deficient adult male mice, with normal G0 controls. It does not demonstrate telomere primacy in ordinary human aging. [Original primary source: PMID 21113150](https://pubmed.ncbi.nlm.nih.gov/21113150/). DOI: 10.1038/nature09603. Access: full_text_partial.

## Adult telomerase intervention can extend lifespan.
Original mouse Methods and Results show ectopic AAV-TERT intervention, small experimental groups and an inactive-TERT control. This supports a restricted model effect; it does not separate every telomere and noncanonical TERT effect. [Original primary source: PMID 22585399](https://pubmed.ncbi.nlm.nih.gov/22585399/). DOI: 10.1002/emmm.201200245. Access: full_text_partial.

## Human genetics links telomeres to age-related outcomes.
Original body distinguishes lower coronary risk from higher cancer risk and weak or null functional/lifespan outcomes. Directional trade-offs are retained rather than equating longer telomeres with uniformly healthier aging. [Original primary source: PMID 31444995](https://pubmed.ncbi.nlm.nih.gov/31444995/). DOI: 10.1111/acel.13017. Access: full_text_partial.

## Telomerase activators offer a human intervention lead.
Original trial body defines the primary endpoint as leukocyte telomere length, with a low-dose signal and nonsignificant high-dose comparison. A biomarker response does not establish extended human healthspan. [Original primary source: PMID 26950204](https://pubmed.ncbi.nlm.nih.gov/26950204/). DOI: 10.1089/rej.2015.1793. Access: full_text_partial.

## Methods wording
Consensus was used to identify literature and cross-check specific claims about study design, endpoints, scope and research gaps. Those claims were checked against original primary abstracts/status records and, for selected studies, original Methods or Results passages. Consensus output was not treated as original full text. Source-specific access depth and receipts are retained. Scite supplied one five-anchor citation-context/tally query; returned contexts were outgoing references, not an audited incoming contradiction set. SciSpace supplied one discovery pass; it added no primary-count credit.